Different policies on prenatal ultrasound screening programmes and induced abortions explain regional variations in infant mortality with congenital malformations

被引:8
作者
Garne, E [1 ]
Berghold, A [1 ]
Johnson, Z [1 ]
Stoll, C [1 ]
机构
[1] Univ So Denmark, Odense, Denmark
关键词
congenital malformations; prenatal ultrasound screening; induced abortions; infant mortality;
D O I
10.1159/000053901
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To compare the impact of induced abortions (IA) on the mortality of infants with congenital malformations in four European regions with different policies on IA and prenatal ultrasound screening for congenital malformations. Methods: A registry-based collection of data on congenital malformations in four different countries: Ireland (Dublin), Denmark (Funen County), Austria (Styria), and France (Strasbourg), Results: The proportion of infant deaths with malformations ranged from 23 to 44% of a II infant deaths with the highest proportion in Dublin, where IA is not allowed and prenatal ultrasound screening not performed, There were highly significant differences in the prevalences of IA (p < 0.001), fetal deaths (p < 0.01), and deaths in infants with congenital malformations (p < 0.001) between the four regions. The differences in total mortality with congenital malformations (IA + fetal deaths + infant deaths) between regions decreased, and only Strasbourg differs significantly from the other three regions. Conclusion: Prenatal ultrasound screening programmes have only a minor impact on total mortality with congenital malformations from 2nd trimester of pregnancy to 1 year of age, but seem to change the time of death which may be important for both the parents and the community. Copyright (C) 2001S.KargerAG,Basel.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 22 条
[1]  
ALLAN LD, 1992, PEDIATR CARDIOL, V13, P1
[2]   Debate about ultrasound screening policies [J].
Antsaklis, AJ .
FETAL DIAGNOSIS AND THERAPY, 1998, 13 (04) :209-215
[3]   Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK [J].
Bull, C .
LANCET, 1999, 354 (9186) :1242-1247
[4]   OMPHALOCELE AND GASTROSCHISIS IN EUROPE - A SURVEY OF 3-MILLION BIRTHS 1980-1990 [J].
CALZOLARI, E ;
BIANCHI, F ;
DOLK, H ;
MILAN, M ;
LECHAT, M ;
LEURQUIN, P ;
GOYENS, S ;
ASTOLFI, G ;
VOLPATO, S ;
AYME, S ;
CALABRO, A ;
CLEMENTI, M ;
TENCONI, R ;
CORNEL, M ;
CUSCHIERI, A ;
GARCIAMINAUR, S ;
GARNE, E ;
GILLEROT, Y ;
GOUJARD, J ;
HANSENKOENIG, D ;
ROULLEAUX, M ;
HOWARD, PJ ;
JOHNSON, Z ;
LILLIS, DF ;
NEVIN, NC ;
NELEN, V ;
PEXIEDER, T ;
PIERINI, A ;
STOLL, C ;
STONE, DH .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 58 (02) :187-194
[5]   EFFECT OF CHANGING THE STILLBIRTH DEFINITION ON EVALUATION OF PERINATAL-MORTALITY RATES [J].
CARTLIDGE, PHT ;
STEWART, JH .
LANCET, 1995, 346 (8973) :486-488
[6]   Does a prenatal diagnosis of congenital heart disease alter short-term outcome? [J].
Copel, JA ;
Tan, ASA ;
Kleinman, CS .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 10 (04) :237-241
[7]   PARENTAL REACTION AND ADAPTABILITY TO THE PRENATAL-DIAGNOSIS OF FETAL DEFECT OR GENETIC-DISEASE LEADING TO PREGNANCY INTERRUPTION [J].
DALLAIRE, L ;
LORTIE, G ;
ROCHERS, MD ;
CLERMONT, R ;
VACHON, C .
PRENATAL DIAGNOSIS, 1995, 15 (03) :249-259
[8]   Management of the fetus with a correctable malformation in Paris maternity units: Evolution 1985-1994 [J].
DeVigan, C ;
Goujard, J ;
Vodovar, V ;
Uzan, S .
FETAL DIAGNOSIS AND THERAPY, 1997, 12 (04) :216-220
[9]  
Druschel C, 1996, PUBLIC HEALTH REP, V111, P359
[10]  
*EUR WORK GROUP, 1997, 7 SCI I PUBL HLTH EU